Rare diseases
Investigational molecules
Locations
Back to Italy24 clinical trials in Forli', Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
ItalyPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
ItalyStudy to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
ItalyStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
ItalyStudy of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis
ItalyStudy on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease
ItalyStudy on Edoxaban for Patients with Atrial Fibrillation and Coronary Syndrome Undergoing PCI
ItalyStudy on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability
ItalyStudy on Pancreas Powder for Digestive Issues in Patients with Unresectable Pancreatic Cancer
ItalyRandomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
ItalyA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
ItalyA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research in Forlì is focused on immune system diseases, especially idiopathic IgA nephropathy (IgAN), with studies looking at how to better control kidney injury and reduce proteinuria. The main aim is to compare targeted treatment approaches with standard care and improve long-term outcomes for people with chronic kidney disease.
These trials are designed to refine renal disease care by matching therapy more closely to disease severity and kidney findings.
Another area of research addresses bacterial infections, with a focus on urinary tract infections in children. The studies aim to test whether shorter antibiotic therapy can safely prevent infection recurrence while maintaining effective treatment.
This work supports better infection management by exploring practical ways to reduce unnecessary antibiotic exposure without lowering care quality.
Research in female urogenital diseases is represented through studies of urinary tract infections, a common condition that can affect patients across different age groups and clinical settings. The goal is to improve treatment strategies and lower the chance of repeat infections.
These trials contribute to more tailored approaches in urogenital health, with attention to both effectiveness and patient safety.
The male urogenital diseases category is also connected to the broader study of urinary tract infections, reflecting interest in how these infections are managed and prevented. The research focuses on improving clinical decision-making around antibiotic treatment.
By examining treatment effectiveness in real-world care, these studies aim to strengthen urological infection management across patient groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
